Aspira Women's Health receives Nasdaq deficiency notice for market value below $35M

Aspira Women's Health Inc.

Nasdaq notified AWH that MVLS was below $35M minimum for 30 consecutive business days.
Company has 180 calendar days, until Dec 30, 2024, to regain compliance.
To comply, MVLS must be ≥ $35M for 10 consecutive business days within grace period.
Alternative: increase stockholders' equity to at least $2.5 million.
No immediate delisting; company evaluating options but can't assure listing maintenance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.